Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ISRCTN06023644Phase 4Completed
Phase 4, open-label, single-arm trial of aspirin in cardiac morbidity, sponsored by King's College London. Primary endpoint: Presence of aspirin resistance. Started Jan 2007; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ISRCTN06023644.